Immune-related adverse events correlate with improved survival in patients undergoing anti-PD1 immunotherapy for metastatic melanoma

被引：0
|
作者：
Alice Indini
Lorenza Di Guardo
Carolina Cimminiello
Michele Prisciandaro
Giovanni Randon
Filippo De Braud
Michele Del Vecchio
机构：
[1] Fondazione IRCCS Istituto Nazionale dei Tumori di Milano,Melanoma Medical Oncology Unit, Department of Medical Oncology and Hematology
[2] Fondazione IRCCS Istituto Nazionale dei Tumori di Milano,Department of Medical Oncology and Hematology
[3] Fondazione IRCCS Istituto Nazionale dei Tumori di Milano,Università degli studi di Milano
来源：
Journal of Cancer Research and Clinical Oncology | 2019年 / 145卷
关键词：
Melanoma; Immunotherapy; Anti-PD1; IrAEs; Vitiligo; Toxicity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：511 / 521
页数：10
相关论文
共 50 条
  • [41] Autoantibody-positivity Before Treatment Is Associated with Immune-related Adverse Events in Melanoma Patients Treated with anti-PD-1
    van Wesemael, Tineke
    Borgers, Jessica
    Gelderman, Kyra
    Verdegaal, Els
    Korse, C. M.
    Welters, M. J. P.
    Kapiteijn, Ellen
    van Houdt, W. J.
    van der Burg, Sjoerd
    Toes, Rene
    Thienen, J. V.
    Haanen, John
    van der Woude, Diane
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4977 - 4979
  • [42] Improved survival among patients with malignant pleural mesotheliomas who develop immune-related adverse events on immunotherapy.
    Offin, Michael
    Egger, Jacklynn V.
    McCarthy, Caroline G.
    Rudneva, Vasilisa
    Beattie, Jason
    Ginsberg, Michelle S.
    Sauter, Jennifer L.
    Rimner, Andreas
    Rusch, Valerie W.
    Adusumilli, Prasad S.
    Zauderer, Marjorie Glass
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [43] Thyroid Immune-Related Adverse Events in Patients with Cancer Treated with anti-PD1/anti-CTLA4 Immune Checkpoint Inhibitor Combination: Clinical Course and Outcomes
    Lui, David Tak Wai
    Lee, Chi Ho
    Tang, Vikki
    Fong, Carol Ho Yi
    Lee, Alan Chun Hong
    Chiu, Joanne Wing Yan
    Leung, Roland Ching Yu
    Kwok, Gerry Gin Wai
    Li, Bryan Cho Wing
    Cheung, Tan To
    Woo, Yu Cho
    Lam, Karen Siu Ling
    Yau, Thomas
    ENDOCRINE PRACTICE, 2021, 27 (09) : 886 - 893
  • [44] Associations between tumor response to pembrolizumab and immune-related adverse events in metastatic melanoma patients
    Geszti, F.
    Czirbesz, K.
    Kenessey, I.
    Liszkay, G.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB24 - AB24
  • [45] Microsatellite Instability Predicts Response to Anti-PD1 Immunotherapy in Metastatic Melanoma
    Roncati, Luca
    ACTA DERMATOVENEROLOGICA CROATICA, 2018, 26 (04) : 341 - 343
  • [46] Correlation of immune-related adverse events with peripheral baseline immune markers and overall survival in patients with metastatic melanoma on ipilimumab and chemotherapy.
    Esfahani, Khashayar
    Thebault, Pamela
    Lapointe, Rejean
    Jamal, Rahima
    Miller, Wilson H.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [47] Immune-Related Adverse Events and Survival Among Patients With Metastatic NSCLC Treated With Immune Checkpoint Inhibitors
    Cook, Sarah
    Samuel, Vanessa
    Meyers, Daniel E.
    Stukalin, Igor
    Litt, Ishjot
    Sangha, Randeep
    Morris, Don G.
    Heng, Daniel Y. C.
    Pabani, Aliyah
    Dean, Michelle
    Navani, Vishal
    JAMA NETWORK OPEN, 2024, 7 (01) : E2352302
  • [48] Multiomic analysis of immune-related adverse events (irAEs) in melanoma patients treated with anti-PD1-based immune checkpoint inhibitors (ICIs)
    Dimitriou, F.
    Cheng, P.
    Saltari, A.
    Staeger, R.
    Tastanova, A.
    Levesque, M.
    Long, G.
    Becher, B.
    Dummer, R.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S275 - S275
  • [49] Ipilimumab and nivolumab induced immune-related adverse events in metastatic mucosal melanoma
    Cao, Yenong
    Afzal, Muhammad Zubair
    Shirai, Keisuke
    BMJ CASE REPORTS, 2021, 14 (08)
  • [50] Association between Immune-Related Adverse Events and Survival in 319 Stage IV Melanoma Patients Treated with PD-1-Based Immunotherapy: An Approach Based on Clinical Chemistry
    Serna-Higuita, Lina Maria
    Amaral, Teresa
    Forschner, Andrea
    Leiter, Ulrike
    Flatz, Lukas
    Seeber, Olivia
    Thomas, Ioannis
    Garbe, Claus
    Eigentler, Thomas Kurt
    Martus, Peter
    CANCERS, 2021, 13 (23)
12345